| 标题 |
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial |
| 网址 | |
| DOI |
10.1016/s0140-6736(23)01245-x
doi
|
| 其它 |
期刊:The Lancet 作者:Hope S Rugo; Aditya Bardia; Frederik Marmé; Javier Cortés; Peter Schmid; et al 出版日期:2023-08-24 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)